Literature DB >> 24782127

iNKT-cell help to B cells: a cooperative job between innate and adaptive immune responses.

Paolo Dellabona1, Sergio Abrignani, Giulia Casorati.   

Abstract

T-cell help to B lymphocytes is one of the most important events in adaptive immune responses in health and disease. It is generally delivered by cognate CD4(+) T follicular helper (T(FH)) cells via both cell-to-cell contacts and soluble mediators, and it is essential for both the clonal expansion of antibody (Ab)-secreting B cells and memory B-cell formation. CD1d-restricted invariant natural killer T (iNKT) cells are a subset of innate-like T lymphocytes that rapidly respond to stimulation with specific lipid antigens (Ags) that are derived from infectious pathogens or stressed host cells. Activated iNKT cells produce a wide range of cytokines and upregulate costimulatory molecules that can promote activation of dendritic cells (DCs), natural killer (NK) cells, and T cells. A decade ago, we discovered that iNKT cells can help B cells to proliferate and to produce IgG Abs in vitro and in vivo. This adjuvant-like function of Ag-activated iNKT cells provides a flexible set of helper mechanisms that expand the current paradigm of T-cell-B-cell interaction and highlights the potential of iNKT-cell targeting vaccine formulations.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  B-cell help; CD1d; T follicular helper cells; vaccines

Mesh:

Substances:

Year:  2014        PMID: 24782127     DOI: 10.1002/eji.201344399

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  19 in total

Review 1.  Innate-like lymphocytes in intestinal infections.

Authors:  Michael S Bennett; June L Round; Daniel T Leung
Journal:  Curr Opin Infect Dis       Date:  2015-10       Impact factor: 4.915

2.  Human mucosal-associated invariant T (MAIT) cells possess capacity for B cell help.

Authors:  Michael S Bennett; Shubhanshi Trivedi; Anita S Iyer; J Scott Hale; Daniel T Leung
Journal:  J Leukoc Biol       Date:  2017-08-14       Impact factor: 4.962

Review 3.  Engaging Natural Killer T Cells as 'Universal Helpers' for Vaccination.

Authors:  Mary Speir; Ian F Hermans; Robert Weinkove
Journal:  Drugs       Date:  2017-01       Impact factor: 9.546

Review 4.  The life (and death) of CD4+ CD28(null) T cells in inflammatory diseases.

Authors:  Ingrid E Dumitriu
Journal:  Immunology       Date:  2015-09-07       Impact factor: 7.397

5.  A semisynthetic carbohydrate-lipid vaccine that protects against S. pneumoniae in mice.

Authors:  Marco Cavallari; Pierre Stallforth; Artem Kalinichenko; Dominea C K Rathwell; Thomas M A Gronewold; Alexander Adibekian; Lucia Mori; Regine Landmann; Peter H Seeberger; Gennaro De Libero
Journal:  Nat Chem Biol       Date:  2014-10-05       Impact factor: 15.040

6.  Intracellular IL-4 and IFN-γ expression in iNKT cells from patients with chronic lymphocytic leukemia.

Authors:  Agnieszka Bojarska-Junak; Małgorzata Waldowska; Justyna Woś; Sylwia Chocholska; Iwona Hus; Waldemar Tomczak; Michał Dzik; Marek Hus; Jacek Roliński
Journal:  Oncol Lett       Date:  2017-11-24       Impact factor: 2.967

Review 7.  Natural Killer T Cells in Cancer Immunotherapy.

Authors:  Shiny Nair; Madhav V Dhodapkar
Journal:  Front Immunol       Date:  2017-09-22       Impact factor: 7.561

8.  Glucosylceramide Synthase Is Involved in Development of Invariant Natural Killer T Cells.

Authors:  Zoran V Popovic; Mariona Rabionet; Richard Jennemann; Damir Krunic; Roger Sandhoff; Hermann-Josef Gröne; Stefan Porubsky
Journal:  Front Immunol       Date:  2017-07-21       Impact factor: 7.561

9.  2B4 Is Dispensable for T-Dependent B Cell Immune Responses, but Its Deficiency Leads to Enhanced T-Independent Responses Due to an Increase in Peritoneal Cavity B1b Cells.

Authors:  Avijit Ray; Cheng-Yin Yuan; Nichole M Miller; Hong Mei; Bonnie N Dittel
Journal:  PLoS One       Date:  2015-08-31       Impact factor: 3.240

Review 10.  CD1-Restricted T Cells During Persistent Virus Infections: "Sympathy for the Devil".

Authors:  Günther Schönrich; Martin J Raftery
Journal:  Front Immunol       Date:  2018-03-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.